Abdominal obesity: A health threat;L'obésité abdominale : une menace pour la santé

Presse Medicale

Volumn 37, Issue 10, 2008, Pages 1407-1414

  Bruckert, Éric ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; COMORBIDITY; DYSLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; OVARY POLYCYSTIC DISEASE; PROTEIN EXPRESSION; SHORT SURVEY; STROKE;

ADIPONECTIN; CORONARY DISEASE; EXERCISE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; OBESITY; RISK FACTORS; STROKE; WEIGHT LOSS;

EID: 53049108459     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.01.021     Document Type: Short Survey

References (29)

1. Després J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., and Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10 (1990) 497-511
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
3. Després J.P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
4. Lemieux I., Poirier P., Bergeron J., Almeras N., Lamarche B., Cantin B., et al. Hypertriglyceridemic waist: A useful screening phenotype in preventing cardiology?. Can J Cardiol 23 (2007) 725-732
5. Lemieux I., Pascot A., Couillard C., Lamarche B., Tchernof A., Almeras N., et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 102 (2000) 179-184
6. Weiss R., Dziura J., Burgert T.S., Tamborlane W.V., Taksali S.E., Yeckel C.W., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 (2004) 2362-2374
7. Hansel B., Giral P., Nobecourt E., Chantepie S., Bruckert E., Chapman M.J., et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89 (2004) 4963-4971
8. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
9. Grundy S.M., Hansen B., Smith Jr. S.C., Cleeman J.I., and Kahn R.A. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
10. Czernichow S., Berttrais S., Preziosi P., Galan P., Hercberg S., and Oppert J.M. Indicators of abdominal adiposity in middle-aged participants of the SU.VI.MAX study: relationships with educational level, smoking status and physical inactivity. Diabetes Metab 30 (2004) 153-159
11. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., and Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163 (2003) 427-436
12. Bastard J.P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87 (2002) 2084-2089
13. Liu Y.M., Moldes M., Bastard J.P., Bruckert E., Viguerie N., Hainque B., et al. Adiponutrin: A new gene regulated by energy balance in human adipose tissue. J Clin Endocrinol Metab 89 (2004) 2684-2689
14. Maachi M., Pieroni L., Bruckert E., Jardel C., Fellahi S., Hainque B., et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 28 (2004) 993-997
15. Janssen I., Katzmarsyk P.T., and Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79 (2004) 379-384
16. Palaniappan L., et al. Predictors of the incident metabolic syndrome in adults. Diabetes Care 27 (2004) 788-793
17. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 2007;3(5):467-72.
18. Rouzi A.A., and Ardawi M.S. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. Fertil Steril 85 2 (2006) 428-435
19. Bruckert E., Giral P., Ratziu V., Poynard T., Chapman M.J., Opolon P., et al. A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Metabolism 51 (2002) 1071-1076
20. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., et al. Liver fibrosis in overweight patients. Gastroenterology 118 (2000) 1117-1123
21. Yusuf S., Hawken S., Ôunpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries. Lancet 366 (2005) 1640-1649
22. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., and Pyrola K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
23. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49 4 (2007) 403-414
24. Guize L., Thomas F., Pannier B., Bean K., Jego B., and Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care 30 9 (2007) 2381-2387
25. Klein S., Fontana L., and Young V.L. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350 (2004) 2549-2557
26. Thorne A., Lonnqvist F., and Apelman J. A pilot study of long-term effects of a novel obesity treatment: omentectomie in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 26 (2002) 193-199
27. Ross I., and Janssen I. Is abdominal fat preferentially reduced in response to exercise-induced weight loss?. Med Sci Sports Exerc 31 (1999) S568-S572
28. Slentz C.A., Aiken L.B., Houmard J.A., Bales C.W., Johnson J.L., Tanner C.J., et al. Inactivity, exercise, and visceral fat. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol 99 (2005) 1613-1618
29. Okura T., Nakata Y., Ohkawara K., Numao S., Katayama Y., Matsuo T., et al. Effects of aerobic exercise on metabolic syndrome improvement in response to weight reduction. Obesity (Silver Spring) 15 10 (2007) 2478-2484